Angelo Gordon & Co’s European Biotech Acquisition Corp. Units EBACU Stock Holding History

Angelo Gordon & Co’s Portfolio EBACU Stock Details EBACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-40,000	Closed	-$394K	–	279
2022 Q1	$394K	Hold	40,000	–	–	0.04%	183
2021 Q4	$396K	Hold	40,000	–	–	0.04%	206
2021 Q3	$398K	Hold	40,000	–	–	0.02%	186
2021 Q2	$400K	Hold	40,000	–	–	0.02%	169
2021 Q1	$403K	Buy	+40,000	New	+$400K	0.04%	159

Other funds holding EBACU

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

SMA

Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return

MTCM

Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return

Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

SIA

Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return

Angelo Gordon & Co's EBACU Position: Q2 2022 in Review

Angelo Gordon & Co sold out of European Biotech Acquisition Corp. Units (EBACU) in Q2 2022, closing a stake of 40,000 shares — an estimated $394K sold.

Angelo Gordon & Co first reported a position in EBACU in Q1 2021 and held it in 5 quarters. The position peaked at $403K in Q1 2021. 20 funds tracked by Wall St. Rank hold EBACU as of Q2 2022.

Angelo Gordon & Co reported no remaining European Biotech Acquisition Corp. Units position as of Q2 2022 after selling out during the quarter.
Angelo Gordon & Co sold 40,000 European Biotech Acquisition Corp. Units shares in Q2 2022, an estimated $394K.
Angelo Gordon & Co first reported a position in European Biotech Acquisition Corp. Units in Q1 2021 and held it in 5 quarters.
Angelo Gordon & Co's European Biotech Acquisition Corp. Units position peaked at $403K in Q1 2021.
20 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Units as of Q2 2022.

Based on Angelo Gordon & Co's 13F filing for Q2 2022, filed 15 Aug 2022.